title: Malignant solitary fibrous tumors of the head and neck: a clinicopathological study of nine consecutive patients.
abstract: Malignant solitary fibrous tumor (MSFT) is one of the angiosarcomas arising from or resembling the components of blood vessels. Because of its rarity, the diagnosis is difficult. Between 1998 and 2008, 24 patients were diagnosed as having hemangiopericytomas (16) and solitary fibrous tumors (8). Nine of them were confirmed to be MSFT and treated at the Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. All patients were treated with surgery as the primary modality. Eight patients received postoperative adjuvant radiation therapy. The average follow-up duration was 4.6 years (range: 6 months-10 years). Of the nine patients reviewed in this study, three died of locoregional or distant metastasis, six survived 6 months-6 years (four survived over 4 years). The size of primary tumor, the number of mitoses per 10 high powered fields and cervical lymph node metastasis seemed to be correlated with poor prognosis in MSFT patients, although the small number of patients did not permit the performance of statistical analysis.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai, China.
authors.forename: X J
authors.initials: XJ
authors.lastname: Yang
authors.forename: J W
authors.initials: JW
authors.lastname: Zheng
authors.forename: W M
authors.initials: WM
authors.lastname: Ye
authors.forename: Y A
authors.initials: YA
authors.lastname: Wang
authors.forename: H G
authors.initials: HG
authors.lastname: Zhu
authors.forename: L Z
authors.initials: LZ
authors.lastname: Wang
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D002681:China; D003937:Diagnosis, Differential; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy; D006393:Hemangiopericytoma / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D054364:Solitary Fibrous Tumors / Q000473:pathology / Q000628:therapy